Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. – UroToday
|
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
UroToday The standard of care for most patients with non-muscle-invasive bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Guérin (BCG), which activates the immune system to recognize and destroy malignant cells and has demonstrated … |
